CAS 1832713-02-6

(3S)-1-[4-[[(2,3,5,6-Tetramethylphenyl)sulfonyl]amino]-1-naphthalenyl]-3-pyrrolidinecarboxylic acid

Description:

The chemical substance known as (3S)-1-[4-[[(2,3,5,6-Tetramethylphenyl)sulfonyl]amino]-1-naphthalenyl]-3-pyrrolidinecarboxylic acid, with the CAS number 1832713-02-6, is characterized by its complex molecular structure, which includes a pyrrolidine ring, a naphthalene moiety, and a sulfonamide functional group. This compound is likely to exhibit specific stereochemistry due to the presence of the (3S) configuration, which can influence its biological activity and interactions. The presence of the tetramethylphenyl group suggests that it may possess significant lipophilicity, potentially affecting its solubility and permeability in biological systems. Additionally, the sulfonamide group is known for its role in various pharmacological applications, including antibacterial and antitumor activities. Overall, this compound's unique structural features may contribute to its potential utility in medicinal chemistry and drug development, although specific biological activities and properties would require further investigation through empirical studies.

Formula: C₂₅H₂₈N₂O₄S

Synonyms:

• RA 839
• (3S)-1-[4-[[(2,3,5,6-Tetramethylphenyl)sulfonyl]amino]-1-naphthalenyl]-3-pyrrolidinecarboxylic acid
• 3-Pyrrolidinecarboxylic acid, 1-[4-[[(2,3,5,6-tetramethylphenyl)sulfonyl]amino]-1-naphthalenyl]-, (3S)-
• (S)-1-(4-((2,3,5,6-Tetramethylphenyl)sulfonamido)naphthalen-1-yl)pyrrolidine-3-carboxylic acid

RA839

CAS: 1832713-02-6

Formula: C₂₅H₂₈N₂O₄S

Purity: 98%

Molecular weight: 452.5658

Ref: IN-DA01ENL8

RA-839

CAS: 1832713-02-6

RA-839

Purity: ≥98%

Molecular weight: 452.57g/mol

Ref: 54-BUP06393

RA-839

CAS: 1832713-02-6

RA-839 is a Keap1 conjugate and Nrf2 signaling activator, and an inhibitor of Keap1/Nrf2 interaction with anticancer activity.

Formula: C₂₅H₂₈N₂O₄S

Purity: 98.38%

Color and Shape: Solid

Molecular weight: 452.57

Ref: TM-T28497

RA 839

CAS: 1832713-02-6

RA 839 is a small molecule that has been shown to inhibit tumor growth by targeting cytosolic proteins and inhibiting the activity of these proteins. It can be used to treat renal cell cancer, as well as other types of cancers with hypoxic tumors. RA 839 has also been found to reduce the production of cytokines in LPS-induced inflammatory responses.

Purity: Min. 95%

Ref: 3D-BR175284